At the news
? NEUTRALIMPACT 2/10 144 filed Jun 11, 2026 at 15:22 ET
Charles Divita III, an officer and director of Teladoc Health, filed a Form 144 notice of intent to sell 18,074 shares of common stock, with an approximate market value of $125,461 based on the filing date. The shares were acquired through restricted stock vesting on June 10, 2026, and the sale appears related to tax withholding obligations from equity award settlement. This is a routine insider sale tied to equity compensation, not a discretionary open-market sale.
- Charles Divita III (Officer and Director) filed Form 144 to sell 18,074 shares of TDOC common stock.
- Estimated sale value: approximately $125,461 based on filing date.
- Shares acquired via restricted stock vesting on June 10, 2026.
- Sale is to cover tax obligations from vested equity award distribution.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access